Detail page

Knowledge Web

Person

Daniela Heidenreich (1976-)

Ärztin

Name	Daniela Heidenreich
Time	1976- (Date of birth and death)
Place	Heidelberg (Wirkungsort) Deutschland
Academic degree	Dr. med.
Profession	Ärztin (characteristic profession)
Variant	Daniela Brigitte Heidenreich
Related	Universität Heidelberg. Medizinische Fakultät Mannheim
Further information	Diss. Medizinische Fakultät; Fachärztin III. Medizinische, Universitätsklinikum Mannheim, Medizinische Fakultät Mannheim der Universität Heidelberg
Record type	Person
GND-Identifier	124462073
Record ID	124462073
Involved in show all Prospective analysis of the attendance behaviour of the participants of a facilitated support group for patients after allogeneic hematopoietic cell transplantation General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents — a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Takotsubo Cardiomyopathy after Systemic Consolidation Therapy with High-Dose Intravenous Cytarabine in a Patient with Acute Myeloid Leukemia Untersuchung der In-vitro-Qualität klinisch genutzter, aber nicht transfundierter Human-Erythrozytenkonzentrate verschiedener Hersteller am Ende der Lagerungsdauer

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Daniela Heidenreich (1976-)

Prospective analysis of the attendance behaviour of the participants of a facilitated support group for patients after allogeneic hematopoietic cell transplantation

General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy

Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents — a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Takotsubo Cardiomyopathy after Systemic Consolidation Therapy with High-Dose Intravenous Cytarabine in a Patient with Acute Myeloid Leukemia

Untersuchung der In-vitro-Qualität klinisch genutzter, aber nicht transfundierter Human-Erythrozytenkonzentrate verschiedener Hersteller am Ende der Lagerungsdauer